Specialty Chemicals

DANIMER SCIENTIFIC INC

Danimer Scientific Inc. released FY2023 Q3 earnings on November 19 After-Market (EST), actual revenue 10.95 M USD (forecast 14.74 M USD), actual EPS -15.7446 USD

Danimer Scientific Inc. released FY2023 9 Months Earnings on November 19 After-Market (EST), actual revenue 35.74 M USD, actual EPS -45.5254 USD

Danimer Scientific Inc. released FY2024 9 Months Earnings on November 19 Pre-Market (EST), with actual revenue of 26.48 M USD and EPS of -25.569 USD

Danimer Scientific Inc. released FY2024 Q3 earnings on November 19 Pre-Market (EST), actual revenue 8.63 M USD (forecast 8.577 M USD), actual EPS -7.2971 USD

Danimer Scientific Inc. released FY2024 semi-annual earnings on August 8 After-Market (EST), actual revenue 17.85 M USD, actual EPS -18.1352 USD

Danimer Scientific Inc. released FY2023 semi-annual earnings on August 8 After-Market EST, with actual revenue of 24.79 M USD and EPS of -29.7809 USD

Danimer Scientific Inc. released FY2024 Q2 earnings on August 8 After-Market (EST), actual revenue 7.628 M USD (forecast 8.981 M USD), actual EPS -7.7829 USD

Danimer Scientific Inc. released FY2023 Q2 earnings on August 8 After-Market (EST), actual revenue 12.87 M USD (forecast 13.9 M USD), actual EPS -15.3979 USD

Danimer Scientific Inc. released FY2024 Q1 earnings on May 7 After-Market (EST), actual revenue 10.22 M USD (forecast 10.73 M USD), actual EPS -10.4889 USD

Danimer Scientific Inc. released FY2023 Q1 earnings on May 7 After-Market (EST), actual revenue 11.93 M USD (forecast 14.39 M USD), actual EPS -14.3828 USD

Danimer Scientific Inc. released FY2022 Q4 earnings on March 29 After-Market (EST), actual revenue 15.32 M USD (forecast 15.31 M USD), actual EPS -11.0657 USD

Danimer Scientific Inc. released FY2022 annual earnings on March 29 After-Market (EST), actual revenue 53.22 M USD (forecast 53.2 M USD), actual EPS -71.1241 USD

Danimer Scientific Inc. released FY2023 annual earnings on March 29 During-Market (EST), actual revenue 46.68 M USD (forecast 51.51 M USD), actual EPS -60.9687 USD

Danimer Scientific Inc. released FY2023 Q4 earnings during market hours on March 29 (EST), with actual revenue of 10.95 M USD (forecast 11.57 M USD) and actual EPS of -15.4423 USD.

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

Shin-Etsu Chemical Co., Ltd.

Givaudan

Symrise

Newmarket

Balchem

Sensient Tech

Flotek Industries

Solesence

Northern Tech

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap